January 2023 - Page 7 of 22

MondayJan 23, 2023 11:15 am

Data443 Risk Mitigation Inc. (ATDS) Announces New Contract Wins; Raises Capital to Fund Future Growth Agenda

In November 2018, Marriott suffered the loss of personal data for almost 383 million guests, highlighting the pitfalls and risks attached to businesses boasting an online profile Gartner revealed that 30% of enterprises would employ data security platforms by 2024, up from a mere 5% in 2019 Data443 caters to the growing need for data discovery, governance, and protection services through its extensive and growing product suite – with services ranging from the data archiving and transfer through to ransomware recovery The company recently embarked on the next leg of its growth trajectory, recently raising over $1.5M with proceeds set…

MondayJan 23, 2023 10:57 am

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) NanoAb May Serve as Therapeutic and Prophylactic as Shown in Preclinical Study

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, today announced additional results in a preclinical proof-of-concept study of its innovative inhaled NanoAb COVID-19 drug. According to the update, the study used an industry-standard animal model to compare weight loss in two groups of hamsters. Hamsters administered a mid-sized 0.66mg dose of the NanoAb three hours prior to infection experienced no significant weight loss over the six-day trial, whereas the untreated control group’s weight declined 12% on average, a highly statistically significant difference (p<0.0005). “We…

MondayJan 23, 2023 10:30 am

Cepton, Inc. (NASDAQ: CPTN) Kicks off the New Year; Launches Vista(R)-X120 Plus — Ultra-Slim, Next-Gen Lidar for ADAS and Automotive Driving Applications

Built upon its predecessor–Vista-X90 lidar–that is being used in Cepton's flagship ADAS lidar program with GM and Koito, the Vista-X120 Plus is designed to significantly enhance lidar performance without compromising reliability, size, power efficiency, and cost Vista-X120 Plus advances the company's vision of enabling safe and autonomous transportation for everyone through mass-market lidar adoption. As a member of the Lidar Coalition, Cepton showcased its new product and a comprehensive portfolio of its lidar solutions at CES 2023, one of the most influential tech events in the world; the company demonstrated its adaptive 3D perception and simulations featuring a Chevy Silverado…

MondayJan 23, 2023 10:15 am

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Unveils Streamlined, Automated Carrier Onboarding Process

Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning, offers a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region, has announced a new, automated and effortless carrier onboarding process. The new process, states the company, makes it even easier qualified carriers to sign up and move loads with Fr8App. The announcement noted that qualified carriers who sign up on the Fr8App platform, can approved and unlock all the platform options in only minutes; users simply follow step-by-step instructions that are provided. The new streamlined process…

MondayJan 23, 2023 9:45 am

MetAlert, Inc. (MLRT) In Strong Position Entering 2023 According to CEO Patrick Bertagna

MetAlert’s CEO, Patrick Bertagna, while appearing in an interview presented by Sequire Spotlight and hosted by Carmel Fisher, expressed his optimism for the new year while also sharing the company’s recent progress He discussed the company’s core objective- increasing the quality of life, and longevity of people living with Alzheimer’s, dementia, and autism (“ADA”) Bertagna also hinted at potential acquisitions by the company, attributing it to extensive efforts over the past couple of years to clean up its balance sheet He noted that as MetAlert’s revenue per user continues to grow, its margins will increase, ultimately placing the company in…

MondayJan 23, 2023 9:00 am

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Is ‘One to Watch’

McEwen Mining is an asset rich gold and silver producer with large exposure to copper McEwen Mining CEO Rob McEwen maintains a 17.3% ownership stake in McEwen Mining with a cost base of roughly $220 million McEwen Copper’s Los Azules project is one of the world’s largest and most economically robust underdeveloped copper projects A proposed IPO of McEwen Copper, with its implied market cap of $258 million, could effectively turbocharge the balance sheet of McEwen Mining McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset rich diversified gold and silver producer in the Americas and has a large exposure…

FridayJan 20, 2023 12:25 pm

QualityStocksNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Reaches Pivotal Milestone to Advance ADI (TM) Technology

Aditxt (NASDAQ: ADTX) recently announced the formation of a U.S.-based wholly owned subsidiary, Adimune Inc., and appointed Joachim-Friedrich Kapp, MD, Ph.D, a 30-year veteran of the pharmaceutical industry, as its chairman and CEO. “Dr. Kapp will be tasked with leading and developing the ADI(TM) immune modulation technology and ADI(TM)-100, Aditxt’s unique and potent antigen-specific immunotherapeutic technology drug candidate, toward clinical trials… Short for Apoptotic DNA Immunotherapy(TM), ADI(TM) is a nucleic acid-based technology platform that utilizes a novel antigen-specific approach to induce immune tolerance by mimicking the way the body naturally induces tolerance to its own tissues. The technology, the company…

FridayJan 20, 2023 12:08 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Eying Broad Market Opportunities for Its Liposomal Joint Homing Peptide

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, recently revealed positive interim data from its dose optimization study of SPU-21 joint homing peptides for subcutaneous administration of anti-arthritic agents. “Silo Pharma provided an update on the ongoing study as of Dec. 30, 2022. During the study, tests were conducted to evaluate the disease-suppressive effects of an SPU-21 peptide-guided anti-arthritis drug versus the drug alone. The drug used in the study was dexamethasone (“DEX”), a corticosteroid used for its anti-inflammatory and immunosuppressant effects. Earlier results of the same study successfully demonstrated that the…

FridayJan 20, 2023 11:15 am

SideChannel Inc. (SDCH) Releases New Product, Enclave(TM), a Zero-Trust Cybersecurity Offering for Small to Mid-Sized Businesses

SideChannel uses microsegmentation to reduce risk, enhance productivity, and implement zero-trust networks Going beyond traditional open Hub & Spoke and Mesh models, Enclave(TM) benefits SideChannel customers with faster breach containment, simplified compliance, and kills VPN connections that limit productivity The global cybersecurity market size is projected to grow from $189.9 billion in 2023 to $266 billion by 2027, at a CAGR of 8.9% SideChannel (OTCQB: SDCH), furthering its mission and vision that cybersecurity should be simple and accessible for small and mid-sized organizations and that they deserve the expertise of an experienced Chief Information Security Officer (“CISO”) at a reasonable…

Site Search

Company Search

Month: January 2023